Chemoinformaics analysis of BETA-SESQUIPHELLANDROL
Molecular Weight | 220.356 | nRot | 4 |
Heavy Atom Molecular Weight | 196.164 | nRig | 8 |
Exact Molecular Weight | 220.183 | nRing | 1 |
Solubility: LogS | -3.49 | nHRing | 0 |
Solubility: LogP | 4.206 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 41.855 |
nHD | 1 | BPOL | 24.077 |
QED | 0.713 |
Synth | 4.44 |
Natural Product Likeliness | 3.552 |
NR-PPAR-gamma | 0.081 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.002 |
HIA | 0.188 |
CACO-2 | -4.569 |
MDCK | 0.0000227 |
BBB | 0.971 |
PPB | 0.939605 |
VDSS | 1.748 |
FU | 0.0460955 |
CYP1A2-inh | 0.154 |
CYP1A2-sub | 0.198 |
CYP2c19-inh | 0.116 |
CYP2c19-sub | 0.819 |
CYP2c9-inh | 0.094 |
CYP2c9-sub | 0.805 |
CYP2d6-inh | 0.01 |
CYP2d6-sub | 0.351 |
CYP3a4-inh | 0.252 |
CYP3a4-sub | 0.326 |
CL | 15.591 |
T12 | 0.227 |
hERG | 0.069 |
Ames | 0.041 |
ROA | 0.09 |
SkinSen | 0.919 |
Carcinogencity | 0.683 |
EI | 0.426 |
Respiratory | 0.956 |
NR-Aromatase | 0.016 |
Antiviral | Yes |
Prediction | 0.827452 |